PTC Therapeutics, Inc. (PTCT) Gross margin 2016–2019
PTC Therapeutics, Inc. (PTCT) gross margin by fiscal year — reported gross profit divided by reported revenue.
96.0%FY2019 · since FY2016: 100.0% → 96.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | 96.0% | +0.8 pp |
| FY2018 | 95.2% | -2.4 pp |
| FY2017 | 97.6% | -2.4 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTCT financial trends
PTCT RevenuePTCT Net incomePTCT Net marginPTCT Gross profitPTCT Operating incomePTCT Operating marginPTCT Operating cash flowPTCT Free cash flowPTCT Capital expendituresPTCT Return on equityPTCT Stock buybacksPTCT Dividends paidPTCT Total assetsPTCT Total liabilitiesPTCT Shareholders’ equityPTCT overview →